How Michael Burry's Picks are Playing Out In 2025 ?
Introduction
In his Q4 2024 13F filing, Michael Burry’s Scion Asset Management disclosed 13 positions valued at $77.4 million. From those reported prices to today’s marks (April 29, 2025), outcomes vary widely: Alibaba up +39.60%, Molina Healthcare up +10.02%, while VF Corp. plunged –46.09% and Bruker –32.34%. Below we update each holding’s reported vs. current price performance and explore Burry’s likely rationale given early 2025 market themes.
Q4 2024 Portfolio at a Glance
| Company (Ticker) | Reported Price | Current Price | % Difference |
|---|---|---|---|
| Alibaba (BABA) | $84.79 | $118.37 | +39.60% |
| American Coastal (ACIC) | $13.46 | $11.51 | –14.49% |
| Baidu (BIDU) | $84.31 | $90.37 | +7.19% |
| Bruker (BRKR) | $58.62 | $39.66 | –32.34% |
| Canada Goose (GOOS) | $10.03 | $8.32 | –17.05% |
| Estée Lauder (EL) | $74.98 | $59.14 | –21.13% |
| HCA Healthcare (HCA) | $300.15 | $332.02 | +10.62% |
| JD.com (JD) | $34.67 | $32.70 | –5.68% |
| Magnera (MAGN) | $18.17 | $14.65 | –19.37% |
| Molina Healthcare (MOH) | $291.05 | $320.20 | +10.02% |
| Oscar Health (OSCR) | $13.44 | $12.62 | –6.10% |
| Pinduoduo (PDD) | $96.99 | $103.09 | +6.29% |
| VF Corp. (VFC) | $21.46 | $11.57 | –46.09% |
China Tech Reassessment
Alibaba, JD.com, Baidu & Pinduoduo
Burry’s China tech bets continue to drive performance. Alibaba is up +39.60% on renewed consumer demand and spin-offs. Baidu rose +7.19% thanks to AI progress. Pinduoduo gained +6.29% on strong user metrics. JD.com fell –5.68% amid margin pressures despite operational improvements.
Healthcare & Insurance
Molina Healthcare, HCA Healthcare, Oscar Health & American Coastal
Defensive picks held up well: Molina Healthcare +10.02% on government-backed stability; HCA Healthcare +10.62% via reliable cash flows. Oscar Health dipped –6.10% in profit-taking, while American Coastal fell –14.49% amidst reinsurance cycle headwinds.
Consumer Brands
Estée Lauder, VF Corp. & Canada Goose
Value contrarians took hits: Estée Lauder –21.13% on travel-retail softness; VF Corp. –46.09% amid apparel weakness; Canada Goose –17.05% due to inventory corrections. Long-term brand recovery remains the thesis.
Industry & Science
Bruker & Magnera
Bruker slid –32.34% despite anticipated R&D spending, while Magnera dropped –19.37% post-spinoff. Both remain watchlist candidates for special-situation upside if industrial demand rebounds.
The Big Picture
- Value vs. Growth: Big winners in China tech and healthcare offset steep losses in consumer and industrial names.
- Rate Environment: Favored cash generators and stable franchises amid rising rates.
- Thematic Diversification: Balanced U.S. and China exposure to manage geopolitical and macro risks.
- Defensive Tilt: Insurance and healthcare helped cushion broader market swings.
Conclusion
From reported filing prices through April 29, 2025, Burry’s Q4 2024 portfolio shows standout gains—Alibaba (+39.60%), HCA Healthcare (+10.62%)—and deep drawdowns—VF Corp. (–46.09%), Bruker (–32.34%). His mix of China tech, defensive healthcare, contrarian consumer, and niche industrial plays reflects a multi-scenario, deep-value framework tailored for early 2025’s market headwinds and opportunities.
Disclaimer
This article is for informational purposes only and does not constitute investment advice. Please conduct your own research or consult a licensed advisor before making any investment decisions.
